$PRAX News

Is Praxis Precision Medicines (PRAX) Priced Too Highly On Book Value?

JP Morgan Initiates Coverage On Praxis Precision Medicine with Overweight Rating, Announces Price Target of $700

HC Wainwright & Co. Reiterates Buy on Praxis Precision Medicine, Maintains $1201 Price Target

HC Wainwright & Co. Reiterates Buy on Praxis Precision Medicine, Maintains $1201 Price Target

BTIG Maintains Buy on Praxis Precision Medicine, Raises Price Target to $826

Praxis Precision Medicine Q2 2026 Earnings Call Transcript

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

HC Wainwright & Co. Reiterates Buy on Praxis Precision Medicine, Maintains $1201 Price Target

Needham Reiterates Buy on Praxis Precision Medicine, Maintains $582 Price Target

Praxis Precision Medicines: Still Potential Upside After Huge Rally (Rating Upgrade)

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Goldman Sachs Maintains Buy on Praxis Precision Medicine, Raises Price Target to $575

Praxis (PRAX) Q2 2026 Earnings Call Transcript

Is Praxis (PRAX) Trading Bigger Losses for Long-Run CNS Ambition With Its Cash War Chest?

Praxis: Commercial Launch Could Smash Expectations (Video)

RBC Capital Maintains Outperform on Praxis Precision Medicine, Raises Price Target to $462

Praxis Precision Medicines, Inc. Q2 2026 Earnings Call Summary

Wells Fargo Maintains Equal-Weight on Praxis Precision Medicine, Raises Price Target to $362

Praxis Precision Medicines, Inc. (PRAX) Q2 2026 Earnings Call Transcript

Praxis Precision Medicines Q2 Earnings Call Highlights